Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Pulse pressure...

    Pulse pressure predicts diabetic retinopathy than systolic blood pressure in diabetics

    Written by Medha Baranwal Baranwal Published On 2019-04-22T19:28:58+05:30  |  Updated On 22 April 2019 7:28 PM IST
    Pulse pressure predicts diabetic retinopathy than systolic blood pressure  in diabetics

    Pulse pressure predicts diabetic retinopathy than systolic blood pressure in diabetics, finds a new study. The study has been published in the Journal of the American Heart Association.


    Diastolic blood pressure (DBP) is also important in addition to systolic blood pressure (SBP) for the prediction of severe diabetic retinopathy (DR) -- a major cause of vision loss and impaired quality of life in patients with diabetes mellitus, according to a recent study.


    The study has found that pulse pressure (PP) -- the difference between SBP and DBP -- is a better predictor of severe diabetic retinopathy, DR in comparison to SBP.


    Evidence of the role of SBP in the development of severe diabetic retinopathy is not strong, although the adverse effect of low DBP has been a partial explanation. Masahiko Yamamoto, Department of Hematology, Endocrinology, and Metabolism, Niigata University, Faculty of Medicine, Niigata, Japan, and colleagues assessed the predictive ability of incident severe diabetic retinopathy between PP which considers both SBP and diastolic blood pressure, compared with SBP.


    The researchers used data from a national health insurance claim-based database in Japan. It included more than 12,000 individuals with diabetes.


    Also Read: AI instantly diagnoses diabetic retinopathy, saves sight

    Key findings of the study include:

    • During a median follow-up of 4.8 years, 165 developed vision-threatening treatment-requiring diabetic eye diseases (i.e., severe diabetic retinopathy).

    • The risk factor most strongly associated with the incidence of severe diabetic retinopathy was hemoglobin A1c: each standard deviation (SD) increase was associated with a significant 2.2-fold increase in risk.

    • In contrast, an increase of one SD in PP was associated with a 39% increased risk of diabetic retinopathy, and each SD increase in systolic blood pressure was associated with a 22% risk increase.

    • In a model simultaneously adjusting for both systolic blood pressure and PP, only the hazard ratio associated with PP remained statistically significant.

    • Diastolic blood pressure and mean blood pressure were not significantly associated with the risk of developing severe diabetic retinopathy.

    • The overall accuracy for predicting the development of severe diabetic retinopathy (as determined by AUROC) was 80% for HbA1c, 58% for PP and 54% for systolic blood pressure.


    Also Read: Midday nap reduces high blood pressure and need for BP drugs

    "PP is not only more strongly associated with incident DR but is a stronger predictor of severe DR than SBP, suggesting the importance of DBP in addition to SBP and the difficulty of administering antihypertensive treatments for prevention of severe DR leading to vision loss given the current lack of any therapy that exclusively targets PP. However, priority should be given to monitoring HbA1c for identifying patients at high risk of severe DR," write the authors.


    For detailed study follow the link: https://doi.org/10.1161/JAHA.118.010627
    blood pressureBPDBPdiabetesdiabetes complicationsdiabetic retinopathyDiastolic blood pressureJournal of the American Heart AssociationMasahiko Yamamotopredictorpulse pressureSBPsevere diabetic retinopathysystolic blood pressurevision loss
    Source : With inputs from Journal of the American Heart Association

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok